Home > Insider Trading > Raptor Pharmaceutical Corp

Raptor Pharmaceutical Corp (RPTP)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

News

First
<< Previous
11 - 19

Raptor Pharmaceutical Corp. (RPTP), Mylan Inc. (MYL), Forest Laboratories, Inc. (FRX): Will You Adopt This Orphan Drug?

Orphan drug status, which is given to drugs meant for the treatment of rare diseases, offers drug developers a path to faster approval and enhanced market exclusivity.

Keep Reading →

September 6th, 2013 - News

Valeant Pharmaceuticals Intl Inc (VRX), GlaxoSmithKline plc (ADR) (GSK) - CAPScall of the Week: Raptor Pharmaceutical Corp. (RPTP)

For years, satirical late-night TV host Stephen Colbert has been running a series on his show called "Better Know a District," which highlights one of the 435 U.S.

Keep Reading →

August 20th, 2013 - News

Regeneron Pharmaceuticals Inc (REGN), Alexion Pharmaceuticals, Inc. (ALXN): Is This Biopharmaceutical Company Ahead Of Its Time?

In most cases, a biopharmaceutical company chooses to develop either high-priced orphan-designated drugs, or therapeutics to treat large patient populations. Yet one company in particular, Regeneron ...

Keep Reading →

July 19th, 2013 - News

Alexion Pharmaceuticals, Inc. (ALXN), BioMarin Pharmaceutical Inc. (BMRN): What Makes a Good Orphan Drug Investment?

Moreover, these Orphan designations are mostly awarded on drugs that treat small populations, but sometimes, these drugs can create massive amounts of revenue, and large valuations are given to the developing...

Keep Reading →

June 28th, 2013 - News

Assessing Raptor Pharmaceutical Corp. (RPTP)'s Agreement With HealthCare Royalty Partners

Raptor Pharmaceutical Corp. (NASDAQ:RPTP) signed an agreement with HealthCare Royalty Partners. On the face, this deal looks good for shareholders injecting much needed capital into the company.

Keep Reading →

June 17th, 2013 - News

Is Astex Pharmaceuticals, Inc. (ASTX) Going to Burn These Hedge Funds?

Astex Pharmaceuticals, Inc. (NASDAQ:ASTX) was in 16 hedge funds' portfolio at the end of March. ASTX investors should be aware of an increase in hedge fund interest in recent months.

Keep Reading →

June 12th, 2013 - News

Merck & Co., Inc. (MRK), AVEO Pharmaceuticals, Inc. (AVEO): This Week in Biotech

With the SPDR S&P Biotech Index up 31% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.

Keep Reading →

May 4th, 2013 - News

Raptor Pharmaceutical Corp. (RPTP), AVEO Pharmaceuticals, Inc. (AVEO) & Two FDA Decisions You Can’t Afford to Miss This Week

Last week we focused on five can't-miss earnings reports.

Keep Reading →

April 29th, 2013 - News

Aegerion Pharmaceuticals, Inc. (AEGR), Raptor Pharmaceutical Corp. (RPTP): Two Orphan Drugmakers With Upcoming Catalysts

Within the next few days, stocks for two orphan drugmakers could either soar or sink. Both Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) and Raptor Pharmaceutical Corp.

Keep Reading →

April 24th, 2013 - News